Drug · DIN 02530287
RYMTI
0.5 ML SINGLE-USE PREFILLED SYRINGE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since August 31, 2022.
- Drug Identification Number (DIN)
- 02530287
- Company (DIN owner)
- Lupin Pharma Canada LimitedLongueuil, Quebec, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Etanercept L04AB01
- Class
- Human
- Record last updated
- August 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ETANERCEPT | 25 MG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 31, 2022: NOC 28898New Drug Submission (NDS)
Other DINs named RYMTI
- DIN 02530295 · Marketed
- DIN 02530309 · Marketed